Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature

dc.contributor.authorTsagiopoulou, Maria
dc.contributor.authorChapaprieta, Vicente
dc.contributor.authorRussiñol, Nuria
dc.contributor.authorGarcía Torre, Beatriz
dc.contributor.authorPechlivanis, Nikolaos
dc.contributor.authorNadeu Prat, Ferran
dc.contributor.authorPapakonstantinou, Nikos
dc.contributor.authorStavroyianni, Niki
dc.contributor.authorChatzidimitriou, Anastasia
dc.contributor.authorPsomopoulos, Fotis
dc.contributor.authorCampo Güerri, Elias
dc.contributor.authorStamatopoulos, Kostas
dc.contributor.authorMartín-Subero, José Ignacio
dc.date.accessioned2023-12-11T11:32:15Z
dc.date.available2024-06-15T05:10:14Z
dc.date.issued2023-06-15
dc.date.updated2023-11-30T11:00:16Z
dc.description.abstractThe chromatin activation landscape of chronic lymphocytic leukemia (CLL) with stereo-typed B-cell receptor immunoglobulin is currently unknown. In this study, we report the results of a whole-genome chromatin profiling of histone 3 lysine 27 acetylation of 22 CLLs from major subsets, which were compared against nonstereotyped CLLs and normal B-cell subpopulations. Although subsets 1, 2, and 4 did not differ much from their non-stereotyped CLL counterparts, subset 8 displayed a remarkably distinct chromatin acti-vation profile. In particular, we identified 209 de novo active regulatory elements in this subset, which showed similar patterns with U-CLLs undergoing Richter transformation. These regions were enriched for binding sites of 9 overexpressed transcription factors. In 78 of 209 regions, we identified 113 candidate overexpressed target genes, 11 regions being associated with more than 2 adjacent genes. These included blocks of up to 7 genes, suggesting local coupregulation within the same genome compartment. Our findings further underscore the uniqueness of subset 8 CLL, notable for the highest risk of Richter's transformation among all CLLs and provide additional clues to decipher the molecular basis of its clinical behavior.ca
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9349572
dc.identifier.issn1528-0020
dc.identifier.pmid36989492
dc.identifier.urihttps://hdl.handle.net/2445/204390
dc.language.isoengca
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1182/blood.2022016587
dc.relation.ispartofBlood, 2023, vol. 141, num. 24, p. 2955-2960
dc.relation.urihttps://doi.org/10.1182/blood.2022016587
dc.rights(c) American Society of Hematology, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationLeucèmia limfocítica crònica
dc.subject.classificationCromatina
dc.subject.otherChronic lymphocytic leukemia
dc.subject.otherChromatin
dc.titleChromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signatureca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Tsagiopoulou et al_accepted version 2023.pdf
Mida:
1.78 MB
Format:
Adobe Portable Document Format